Biofrontera AG Sponsored ADR Total non-current liabilities

Total non-current liabilities of BFAGY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Total non-current liabilities growth rates and interactive chart.


Highlights and Quick Summary

  • Total non-current liabilities for the quarter ending March 31, 2022 was $1.27 Million (a -95.01% decrease compared to previous quarter)
  • Year-over-year quarterly Total non-current liabilities decreased by -97.37%
  • Annual Total non-current liabilities for 2021 was $1.46 Million (a -96.86% decrease from previous year)
  • Annual Total non-current liabilities for 2020 was $46.5 Million (a 12.79% increase from previous year)
  • Annual Total non-current liabilities for 2019 was $41.2 Million (a 132.74% increase from previous year)
Visit stockrow.com/BFAGY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Total non-current liabilities of Biofrontera AG Sponsored ADR

Most recent Total non-current liabilitiesof BFAGY including historical data for past 10 years.

Interactive Chart of Total non-current liabilities of Biofrontera AG Sponsored ADR

Biofrontera AG Sponsored ADR Total non-current liabilities for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $1.27
2021 $25.45 $48.3 $48.23 $1.46
2020 $55.86 $43.23 $40.37 $46.53
2019 $46.54 $25.62 $41.25
2018 $15.39 $17.72
2017 $14.98 $9.22 $13.96
2016 $3.98 $3.98

Business Profile of Biofrontera AG Sponsored ADR

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic